Illumina, Inc. (ilmn)
ILMN Valuation
| P/E (trailing) | 46.10 |
| P/E (forward) | 41.83 |
| EV/EBITDA | 34.56 |
| Price/Sales | 8.58 |
| Price/Book | 13.59 |
| Market cap | $38.56B |
Start Free — open ILMN in Vest Terminal
Access live data, filings, ownership, and analysis for Illumina, Inc..
Illumina, Inc. FAQ
What does Illumina, Inc. (ILMN) do?
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagent…
What is ILMN's P/E ratio?
Illumina, Inc. has a trailing P/E of 46.10× based on publicly available market data.
Does ILMN pay a dividend?
Indicated dividend yield: none reported. Confirm ex-dates and payout history in Vest Terminal.
What sector is ILMN in?
Illumina, Inc. is classified in Healthcare (Diagnostics & Research) on NMS.
What is ILMN's market capitalization?
Approximate market cap: $38.56B.
What are the main risks for ILMN?
Key risks include above-average volatility (beta 1.47), elevated valuation, among factors on this page.
What are the strengths of ILMN?
Potential positives include revenue growth of 9.4% year-over-year, return on equity near 32.3% — efficient use of shareholder capital.
Where can I get analyst estimates for ILMN?
Public analyst price targets and consensus for Illumina, Inc. are on the free /stocks/ilmn/estimates page. Deeper estimate history and models are available in Vest Terminal.